UBS Maintains Neutral on Bath & Body Works, Lowers Price Target to $17

Benzinga Newsdesk www.benzinga.com Negative 84.9%

Neg 84.9% Neu 0% Pos 0%

UBS analyst Jay Sole maintains Bath & Body Works (NYSE:BBWI) with a Neutral and lowers the price target from $19 to $17.